Skip to content
Recall Observatory FDA recall evidence

Drug product

Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01

D-0087-2023

December 16, 2022

Class II

Product summary

Firm
Aurolife Pharma, LLC
Event
Event 91319
Status
Ongoing
Classification
Class II
Quantity
7344 bottles
Official record key
drug-enforcement:D-0087-2023

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lots: 01422002A1, Expiry: 12/2023; 01421078A3, Expiry: 09/2023

Distribution pattern: Nationwide in the USA and Puerto Rico.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications